Outpace Bio Expands Seattle Presence with Cell Therapy Research Hub & Collaborations with Leading Experts in Protein Design & Cancer Immunotherapy
22 mai 2023 08h00 HE
|
Outpace Bio
Seattle, WA, May 22, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced the...
Outpace Bio to Present New Data on OutSmart™ IL-2/15, a CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity, at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
18 mai 2023 08h00 HE
|
Outpace Bio
Seattle, WA, May 18, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced it will...
Yasheng Group Reports Financial Results for the First Quarter of 2023:
10 mai 2023 06h00 HE
|
Yasheng Group
SAN JOSE, CA, May 10, 2023 (GLOBE NEWSWIRE) -- SAN JOSE, CA--(May 10, 2023) - Yasheng Group, (OTC: HERB), an agricultural company with United States headquarters in San Jose,...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Announces Presentation at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
09 mai 2023 09h00 HE
|
Outpace Bio
Seattle, WA, May 09, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced that an...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Strengthens Executive Leadership Team with Key Appointments
04 mai 2023 08h00 HE
|
Outpace Bio
Seattle, WA, May 04, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced two key leadership appointments....
Dalriada brings in former Evotec executive Adam Davenport to lead strategy execution as Chief R&D Officer
03 mai 2023 02h00 HE
|
Dalriada
TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today that it has strengthened its executive...
Dalriada further strengthens small molecule discovery expertise with appointment of veteran Dr. Frosty Loechel as SVP Biology, Discovery Strategy group
19 avr. 2023 02h00 HE
|
Dalriada
TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Dalriada, a leading Canadian contract research organization specializing in small molecule therapies, announces today the appointment of Frosty Loechel,...
Outpace Bio, a Leader in Protein Design & Cell Engineering, Adds Bahija Jallal to Board of Directors
23 mars 2023 09h00 HE
|
Outpace Bio
Seattle, WA, March 23, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced that Dr. Bahija Jallal has joined...
Yasheng Group Notifies FINRA of Plan to Pay Preferred Dividend to Common Shareholders
01 mars 2023 06h00 HE
|
Yasheng Group
San Jose, CA, March 01, 2023 (GLOBE NEWSWIRE) -- Yasheng Group Notifies FINRA of Plan to Pay Preferred Dividend to Common Shareholders; Begins Raising Capital for our Subsidiary, Jove Pharmaceutics...
Pain Intensity in Sickle Cell Disease
14 nov. 2022 10h00 HE
|
Experimental Biology and Medicine
WASHINGTON, Nov. 14, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 17, September, 2022) improves our understanding of pain phenotypes...